Diabetes Mellitus, Type 2

"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Descriptor ID	D003924
MeSH Number(s)	C18.452.394.750.149 C19.246.300
Concept/Terms	Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus, Noninsulin-Dependent Diabetes Mellitus, Ketosis-Resistant Diabetes Mellitus, Ketosis Resistant Ketosis-Resistant Diabetes Mellitus Diabetes Mellitus, Non Insulin Dependent Diabetes Mellitus, Non-Insulin-Dependent Non-Insulin-Dependent Diabetes Mellitus Diabetes Mellitus, Stable Stable Diabetes Mellitus Diabetes Mellitus, Type II NIDDM Diabetes Mellitus, Noninsulin Dependent Diabetes Mellitus, Maturity-Onset Diabetes Mellitus, Maturity Onset Maturity-Onset Diabetes Mellitus Maturity Onset Diabetes Mellitus MODY Diabetes Mellitus, Slow-Onset Diabetes Mellitus, Slow Onset Slow-Onset Diabetes Mellitus Type 2 Diabetes Mellitus Noninsulin-Dependent Diabetes Mellitus Noninsulin Dependent Diabetes Mellitus Maturity-Onset Diabetes Diabetes, Maturity-Onset Maturity Onset Diabetes Type 2 Diabetes Diabetes, Type 2 Diabetes Mellitus, Adult-Onset Adult-Onset Diabetes Mellitus Diabetes Mellitus, Adult Onset

Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Glucose Metabolism Disorders [C18.452.394]
Diabetes Mellitus [C18.452.394.750]
Diabetes Mellitus, Type 2 [C18.452.394.750.149]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Mellitus, Type 2 [C19.246.300]

Below are MeSH descriptors whose meaning is related to "Diabetes Mellitus, Type 2".

Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".

Diabetes Mellitus, Type 2
Diabetes Mellitus, Lipoatrophic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.

Bar chart showing 596 publications over 27 distinct years, with a maximum of 43 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
2000	1	1	2
2001	2	1	3
2002	5	0	5
2003	12	0	12
2004	8	2	10
2005	18	6	24
2006	13	1	14
2007	13	3	16
2008	13	2	15
2009	13	6	19
2010	22	0	22
2011	21	2	23
2012	23	3	26
2013	18	5	23
2014	34	5	39
2015	31	2	33
2016	26	7	33
2017	28	3	31
2018	20	2	22
2019	29	3	32
2020	21	4	25
2021	32	3	35
2022	31	0	31
2023	42	1	43
2024	28	7	35
2025	20	2	22

Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.

Yan A, Kundu S, Samuels DC, Bailin S, Xu K, So-Armah K, Butt AA, Gerschenson M, Goetz MB, Doyle M, Tracy R, Marconi VC, Justice A, Freiberg M, Koethe JR, Hulgan T. Mitochondrial DNA Haplogroups, Biomarkers of Inflammation and Immune Activation, and Risk of Diabetes in Veterans With and Without Human Immunodeficiency Virus. J Infect Dis. 2025 Dec 20; 232(6):e1003-e1011.

View in: PubMed
Tjaden AH, Braffett BH, Butera NM, Araneta MR, Carmichael O, Groessl EJ, Hazuda HP, Hoskin MA, Ibebuogu U, Magee MF, Mau M, Stich T, Soliman D, Wallia A, Temprosa M, Golden SH. Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS). Diabetes Care. 2025 Oct 01; 48(10):1685-1694.

View in: PubMed
Pradhan P, Wen W, Powers AC, Warren Andersen S, Sanderson M, Lipworth L, Zheng W. Associations of Type 2 Diabetes with Risk of Overall and Site-Specific Cancers in a Cohort of Predominantly Low-Income Racially Diverse Populations. Cancer Epidemiol Biomarkers Prev. 2025 Sep 02; 34(9):1627-1634.

View in: PubMed
Taira DA, Tengan K, Takata J, Porter C, Ranken MS, Sentell TL, Seto TB. Exploring Diabetes Clinical Trial Participation: A Diverse Group Interview Study. Ther Innov Regul Sci. 2026 Jan; 60(1):172-181.

View in: PubMed
Ibraheem O, Ibikunle PD, Gabriel-Ajobiewe RAO, Oyeniran OH, Sodipe GO, Komolafe TR, Komolafe K, Oyewole OT, Ogwa EC, Jeje TO. Bacillus subtilis 7A Enhances the Nutritional Quality of Velvet Bean (Mucuna pruriens Linn.) Seeds and Potentiates Its Role in the Management of Type II Diabetes Mellitus. J Food Sci. 2025 Aug; 90(8):e70446.

View in: PubMed
Abbah QS, Amenyenu E, Aryee ANA, Onuh JO. Functional Carbohydrates as Innovative Food Ingredients in Diabetes Management: A Succinct Review. J Food Sci. 2025 Jul; 90(7):e70372.

View in: PubMed
Wang W, Davis PB, Qi X, Gurney M, Perry G, Volkow ND, Kaelber DC, Xu R. Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study. J Alzheimers Dis. 2025 Aug; 106(4):1509-1522.

View in: PubMed
Rosenstock J, Hsia S, Nevarez Ruiz L, Eyde S, Cox D, Wu WS, Liu R, Li J, Fern?ndez Land? L, Denning M, Ludwig L, Chen Y. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. N Engl J Med. 2025 Sep 18; 393(11):1065-1076.

View in: PubMed
Jacobs S, Klapp R, Shvetsov YB, Kristal BS, Setiawan VW, Le Marchand L, Maskarinec G. Prospective association of a Lifestyle Risk Factor Index with type 2 diabetes in the Multiethnic Cohort. Eur J Nutr. 2025 Jun 16; 64(5):222.

View in: PubMed
Jeddi S, Kashfi K, Ghasemi A. The potential role of nitrate, a nitric oxide donor, in the prevention and treatment of diabetic osteoporosis. Front Endocrinol (Lausanne). 2025; 16:1480838.

View in: PubMed

People

Explore

Similar Concepts

Top Journals